BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 14, 2000
View Archived Issues
New PDE4 inhibitors tested for antiinflammatory activities, GI side effects
Read More
Aphton's antigastrin vaccine increases survival in advanced pancreatic cancer; nears U.S. trials
Read More
Oxigene announces promising clinical results of CA4P in advanced solid tumors
Read More
Preclinical results for Avax's AC Vaccine technology in breast cancer presented at AACR
Read More
Sonus renegotiates EchoGen marketing rights with Abbott
Read More
Delivery of factor VIII gene using lentiviral vectors reported by Cell Genesys
Read More
AACR annual meeting chosen by ProIX as forum for presentation of novel class of redox regulators
Read More
Chirocaine launched in U.S. for anesthesia and pain management
Read More
Chinese evaluate new triptolide derivative T-12 with promising antitumor activity
Read More
Immune Response identifies genes involved in nerve repair
Read More
Lorus seeks to raise 30 million dollars in Canada to finance development programs
Read More
Oral calcitonin enters phase I/II trials
Read More
Forest signs agreement with Merckle for U.S. development and marketing of ML-3000
Read More
Potent and selective dual cdk1/cdk2 inhibitor emerges from Novartis R&D
Read More
Selective COX-2 inhibitor reported at AACR meeting to possess antiangiogenic and antitumor activity
Read More
AstraZeneca files NDA for zolmitriptan in Japan
Read More
Design and pharmacology of TSE-424, a potential osteoporosis therapy
Read More
FDA grants priority review to Zelmac for IBS
Read More
New NK1 antagonists with improved properties patented by Menarini
Read More
Yamanouchi prepares series of potent V1 receptor antagonists
Read More
Pfizer presents new therapeutics for atherosclerosis and associated conditions
Read More
New anti-H. pylori agents from Byk Gulden particularly suitable for administration by the oral route
Read More
Recent patent covers Icos's new phosphodiesterase inhibitors and their use
Read More
Novel series of PDE5 inhibitors claimed by Bristol-Myers Squibb for erectile dysfunction Rx
Read More
Parkinson's disease patients may benefit from implanted porcine embryonic cells
Read More
High antigen response to a single dose of liposomal hepatitis A vaccine
Read More
Sitafloxacin goes head-to-head with imipenem/cilastatin in phase II comparative trial
Read More
NPS Pharmaceuticals highlights clinical development program
Read More